Clinical Trials Browser

Phase 2 × Genetic Testing × 90 days × Clear all

NCT01334021 2026-03-09

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Phase 2 Active not recruiting

Anatomic Stage I Breast Cancer AJCC v8

NCT06632977 2026-03-04

PREDICT

Phase 2 Recruiting

Prostatic Neoplasms